Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.62 - $2.35 $40,255 - $152,583
64,929 New
64,929 $40,000
Q4 2023

Feb 14, 2024

BUY
$1.28 - $2.85 $29,548 - $65,792
23,085 New
23,085 $47,000
Q1 2023

May 15, 2023

BUY
$2.13 - $3.74 $126,326 - $221,811
59,308 New
59,308 $164,000
Q2 2022

Aug 15, 2022

SELL
$1.77 - $4.34 $124,402 - $305,032
-70,284 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$4.03 - $12.19 $14,423 - $43,628
3,579 Added 5.37%
70,284 $290,000
Q4 2021

Feb 14, 2022

BUY
$8.76 - $13.71 $277,306 - $434,003
31,656 Added 90.32%
66,705 $858,000
Q3 2021

Nov 15, 2021

BUY
$6.41 - $13.54 $47,966 - $101,319
7,483 Added 27.15%
35,049 $379,000
Q2 2021

Aug 16, 2021

SELL
$8.13 - $10.2 $9,040 - $11,342
-1,112 Reduced 3.88%
27,566 $252,000
Q1 2021

May 17, 2021

SELL
$4.07 - $27.11 $14,220 - $94,722
-3,494 Reduced 10.86%
28,678 $270,000
Q4 2020

Feb 16, 2021

BUY
$2.57 - $4.22 $82,682 - $135,765
32,172 New
32,172 $127,000
Q3 2020

Nov 16, 2020

SELL
$2.63 - $8.09 $179,918 - $553,436
-68,410 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$5.69 - $8.17 $225,619 - $323,956
39,652 Added 137.88%
68,410 $454,000
Q1 2020

May 15, 2020

BUY
$5.47 - $11.3 $157,306 - $324,965
28,758 New
28,758 $167,000
Q2 2019

Aug 14, 2019

SELL
$9.2 - $15.7 $109,866 - $187,489
-11,942 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$9.97 - $18.96 $167,376 - $318,300
-16,788 Reduced 58.43%
11,942 $159,000
Q4 2018

Feb 14, 2019

BUY
$11.61 - $31.1 $333,555 - $893,503
28,730 New
28,730 $444,000

Others Institutions Holding GRTS

About Gritstone bio, Inc.


  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.